Cormorant Asset Management’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $22.6M | Buy |
|
|||||
|
2023
Q3 | $218K | Hold |
|
|||||
|
2023
Q2 | $384K | Hold |
|
|||||
|
2023
Q1 | $402K | Hold |
|
|||||
|
2022
Q4 | $392K | Hold |
|
|||||
|
2022
Q3 | $524K | Hold |
|
|||||
|
2022
Q2 | $1.03M | Hold |
|
|||||
|
2022
Q1 | $2.69M | Hold |
|
|||||
|
2021
Q4 | $4.08M | Hold |
|
|||||
|
2021
Q3 | $4.27M | Hold |
|
|||||
|
2021
Q2 | $7.5M | Sell |
|
|||||
|
2021
Q1 | $11.9M | Hold |
|
|||||
|
2020
Q4 | $9.48M | Hold |
|
|||||
|
2020
Q3 | $9.69M | Sell |
|
|||||
|
2020
Q2 | $10.7M | Sell |
|
|||||
|
2020
Q1 | $7.53M | Hold |
|
|||||
|
2019
Q4 | $9.61M | Hold |
|
|||||
|
2019
Q3 | $8.88M | Hold |
|
|||||
|
2019
Q2 | $8.45M | Sell |
|
|||||
|
2019
Q1 | $6.38M | Buy |
|